206 related articles for article (PubMed ID: 35355759)
1. Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization.
Pakhomov SP; Orlova VS; Verzilina IN; Sukhih NV; Nagorniy AV; Matrosova AV
Arch Razi Inst; 2021 Nov; 76(5):1461-1468. PubMed ID: 35355759
[TBL] [Abstract][Full Text] [Related]
2. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
3. Moderate-to-severe ovarian hyperstimulation syndrome: A retrospective multivariate logistic regression analysis in Chinese patients.
Ma T; Niu Y; Wei B; Xu L; Zou L; Che X; Wang X; Tang D; Huang R; Chen B
Adv Clin Exp Med; 2020 Jan; 29(1):85-90. PubMed ID: 31990458
[TBL] [Abstract][Full Text] [Related]
4. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
[TBL] [Abstract][Full Text] [Related]
5. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome.
Jellad S; Haj Hassine A; Basly M; Mrabet A; Chibani M; Rachdi R
J Gynecol Obstet Hum Reprod; 2017 Jan; 46(1):87-91. PubMed ID: 28403961
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Hyperstimulation Syndrome Is Associated with a High Secondary Sex Ratio in Fresh IVF Cycles with Cleavage-Stage Embryo Transfer: Results for a Cohort Study.
Jia Q; Fang L; Wang Z; Wu Z; Yan Y; Liu B; Cheng JC; Sun YP
Reprod Sci; 2021 Dec; 28(12):3341-3351. PubMed ID: 34081318
[TBL] [Abstract][Full Text] [Related]
8. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.
Humaidan P; Nelson SM; Devroey P; Coddington CC; Schwartz LB; Gordon K; Frattarelli JL; Tarlatzis BC; Fatemi HM; Lutjen P; Stegmann BJ
Hum Reprod; 2016 Sep; 31(9):1997-2004. PubMed ID: 27343272
[TBL] [Abstract][Full Text] [Related]
9. Beyond the Umbrella: A Systematic Review of the Interventions for the Prevention of and Reduction in the Incidence and Severity of Ovarian Hyperstimulation Syndrome in Patients Who Undergo In Vitro Fertilization Treatments.
Palomba S; Costanzi F; Nelson SM; Besharat A; Caserta D; Humaidan P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762488
[TBL] [Abstract][Full Text] [Related]
10. The effect of luteal GnRH antagonist on moderate and severe early ovarian hyperstimulation syndrome during in vitro fertilization treatment: a prospective cohort study.
Zeng C; Shang J; Jin AM; Wu PL; Li X; Xue Q
Arch Gynecol Obstet; 2019 Jul; 300(1):223-233. PubMed ID: 31004220
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.
Sun B; Ma Y; Li L; Hu L; Wang F; Zhang Y; Dai S; Sun Y
Front Endocrinol (Lausanne); 2020; 11():615957. PubMed ID: 33542709
[TBL] [Abstract][Full Text] [Related]
12. The development of ovarian hyperstimulation syndrome in the implementation of assisted reproductive technology in women with a background of endocrine pathology.
Bachmakova NV; Dubrovina OS; Lisovskaya TV; Melkozerova OA; Maysina EN; Sentiurina LB
Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():25-9. PubMed ID: 25200824
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose aspirin on the development of ovarian hyperstimulation syndrome and outcomes of assisted reproductive techniques in the women with PCOS, a randomized double-blinded clinical trial.
Namavar Jahromi B; Zolghadri J; Rahmani E; Alipour S; Anvar Z; Zarei A; Keramati P
Taiwan J Obstet Gynecol; 2019 Mar; 58(2):255-260. PubMed ID: 30910149
[TBL] [Abstract][Full Text] [Related]
14. Development of ovarian hyperstimulation syndrome: interrogation of key proteins and biological processes in human follicular fluid of women undergoing in vitro fertilization.
Jarkovska K; Kupcova Skalnikova H; Halada P; Hrabakova R; Moos J; Rezabek K; Gadher SJ; Kovarova H
Mol Hum Reprod; 2011 Nov; 17(11):679-92. PubMed ID: 21697218
[TBL] [Abstract][Full Text] [Related]
15. [Ovarian hyperstimulation syndrome after stimulation with highly purified hMGfor in vitro fertilization: Observational study SHOview].
Barrière P; Dewailly D; Duhamel A; Gayet V
Gynecol Obstet Fertil Senol; 2017 May; 45(5):283-290. PubMed ID: 28461237
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization.
Enskog A; Henriksson M; Unander M; Nilsson L; Brännström M
Fertil Steril; 1999 May; 71(5):808-14. PubMed ID: 10231037
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein response is higher in early than in late ovarian hyperstimulation syndrome.
Korhonen KV; Savolainen-Peltonen HM; Mikkola TS; Tiitinen AE; Unkila-Kallio LS
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():162-168. PubMed ID: 27865939
[TBL] [Abstract][Full Text] [Related]
18. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
19. Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women.
Korhonen K; Unkila-Kallio L; Alfthan H; Hämäläinen E; Tiitinen A; Mikkola T; Tapanainen J; Savolainen-Peltonen H
Arch Gynecol Obstet; 2020 Jun; 301(6):1569-1578. PubMed ID: 32372340
[TBL] [Abstract][Full Text] [Related]
20. Unpredictable cases of complicated ovarian hyperstimulation in IVF.
Delvigne A; Vandromme J; Demeestere I; Leroy F
Int J Fertil Womens Med; 1997; 42(4):268-70. PubMed ID: 9309462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
